Rockenstein; Edward

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rockenstein; Edward.The latest application filed is for "compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them".

Company Profile

1.15.17

Rockenstein; Edward - La Jolla CA
Rockenstein; Edward - Chula Vista CA US
Rockenstein; Edward - San Diego CA
Rockenstein; Edward - Spring Valley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them Grant 10,947,302 - Masliah , et al. March 16, 2	2021-03-16
Compositions Targeting 3-repeat Tau For The Treatment Of Neurodegenerative Disorders, And Methods For Making And Using Them App 20200181245 - MASLIAH; Eliezer ; et al.	2020-06-11
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20160184416 - Schenk; Dale B. ; et al.	2016-06-30
Treatment and delay of outset of synucleinopathic and amyloidogenic disease Grant 9,034,337 - Schenk , et al. May 19, 2	2015-05-19
Compounds for reversing and inhibiting protein aggregation, and methods for making and using them Grant 8,946,165 - Masliah , et al. February 3, 2	2015-02-03
Compounds for inhibiting protein aggregation, and methods for making and using them Grant 8,450,481 - Masliah , et al. May 28, 2	2013-05-28
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20120201842 - Schenk; Dale B. ; et al.	2012-08-09
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20120142902 - Schenk; Dale B. ; et al.	2012-06-07
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,147,833 - Schenk , et al. April 3, 2	2012-04-03
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,092,801 - Schenk , et al. January 10, 2	2012-01-10
Compounds For Reversing And Inhibiting Protein Aggregation, And Methods For Making And Using Them App 20110223240 - Masliah; Eliezer ; et al.	2011-09-15
Treatment and delay of onset of synucleinopathic and amyloidogenic disease Grant 7,919,088 - Schenk , et al. April 5, 2	2011-04-05
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100278814 - Schenk; Dale B. ; et al.	2010-11-04
Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them Grant 7,795,495 - Masliah , et al. September 14, 2	2010-09-14
Compounds For Inhibiting Protein Aggregation, And Methods For Making And Using Them App 20100226969 - Masliah; Eliezer ; et al.	2010-09-09
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20100086545 - Schenk; Dale B. ; et al.	2010-04-08
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100031377 - Schenk; Dale B ; et al.	2010-02-04
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20090208487 - Schenk; Dale B. ; et al.	2009-08-20
Human .alpha. synuclein expressing transgenic mice Grant 7,459,601 - Masliah , et al. December 2, 2	2008-12-02
Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease App 20080175838 - Schenk; Dale B. ; et al.	2008-07-24
Transgenic mouse model for neurodegenerative diseases Grant 7,393,994 - Masliah , et al. July 1, 2	2008-07-01
Method For Screening For Anti-amyloidogenic Properties And Method For Treatment Of Neurodegenerative Disease App 20080051337 - Masliah; Eliezer ; et al.	2008-02-28
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20080014194 - Schenk; Dale B. ; et al.	2008-01-17
Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents Grant 7,276,643 - Masliah , et al. October 2, 2	2007-10-02
Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease Grant 7,226,746 - Masliah , et al. June 5, 2	2007-06-05
Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease App 20050086711 - Masliah, Eliezer ; et al.	2005-04-21
Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease App 20040128706 - Masliah, Eliezer ; et al.	2004-07-01
Development of transgenic model for interventions in neurodegenerative diseases App 20030056231 - Masliah, Eliezer ; et al.	2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.